Landec/LFCR

$8.03

-1.95%
-
1D1W1MYTD1YMAX

About Landec

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company and its subsidiaries design, develop, manufacture, and sell differentiated products for food and biomaterials markets, and license technology applications to partners. The Company specializes in specialty formulation, aseptic filling, and final packaging of both complex medical devices and injectable pharmaceuticals. It manufactures commercial products at its three cGMP facilities. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form as well as formulated and filled syringes and vials for injectable products used in treating a broad spectrum of medical conditions and procedures. It sells products utilizing hyaluronan that is distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets.
Ticker
LFCR
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
CEO
James Hall
Employees
689
Headquarters
Chaska, United States

Landec Metrics

BasicAdvanced
$248.34M
Market cap
-
P/E ratio
-$3.38
EPS
1.05
Beta
-
Dividend rate

What the Analysts think about Landec

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 2 analysts.
12.08% upside
High $10.00
Low $8.00
$8.03
Current price
$9.00
Average price target

Landec Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-114.6% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$31.5M
-56.07%
Net income
$-36.1M
-45.3%
Profit margin
-114.6%
24.5%

Landec Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 137.33%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.32
-$0.24
-$0.22
-$0.89
-
Expected
-$0.14
-$0.04
-$0.13
-$0.38
-$0.23
Surprise
137.04%
500%
69.23%
137.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Landec stock

Buy or sell Landec stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing